“The COVID-19 vaccine is the only childhood vaccine that was tested in a placebo-controlled trial.”

• The claim contains a kernel of truth in that the pediatric COVID-19 vaccine trials (e.g., Pfizer-BioNTech's trials in adolescents and in children 5-11) did use an inert saline placebo, which is the 'purest' form of placebo control and is not universal in vaccine licensure.
• Many vaccines on the modern childhood schedule were licensed or updated using active-comparator trials or immunobridging (antibody-response) studies rather than new saline-placebo efficacy trials — e.g., Prevnar 7 was tested against a meningococcal C conjugate control, Prevnar 13 against Prevnar 7, Gardasil trials largely used an aluminum-adjuvant (AAHS) control rather than saline, and annual influenza strain changes are not re-tested against placebo.
• Once a vaccine is licensed and recommended, placebo-controlled trials of the same antigen in children are generally considered unethical, so newer formulations of older vaccines typically are not placebo-tested — a real limitation that the claim exploits.
• Long-term (multi-year) placebo-controlled follow-up is rare for childhood vaccines; most placebo arms are crossed over or followed for months rather than years, so the claim's underlying complaint about the extent of placebo testing is not wholly invented.

• The 1954 Francis Field Trial of the Salk inactivated polio vaccine enrolled roughly 400,000 children in a double-blind, saline-placebo-controlled design — decades before COVID-19 vaccines existed — and is one of the largest placebo-controlled trials ever conducted.
• Both modern rotavirus vaccines were licensed on the basis of enormous placebo-controlled infant trials: the RotaTeq REST trial randomized ~68,000 infants to vaccine or placebo (Vesikari et al., NEJM 2006), and the Rotarix trial randomized ~63,000 infants to vaccine or placebo (Ruiz-Palacios et al., NEJM 2006).
• The live attenuated varicella (Oka/Merck) vaccine was shown efficacious in a double-blind, placebo-controlled trial in healthy children (Weibel et al., NEJM 1984) before licensure.
• Acellular pertussis vaccines were evaluated in the 1990s in large randomized trials in Italy and Sweden that included placebo (DT-only or true placebo) arms in children.
• Haemophilus influenzae type b polysaccharide/conjugate vaccines were evaluated in placebo-controlled field trials (notably the Finnish Hib trial and the Navajo PRP-OMP trial) in infants.
• Other childhood-schedule vaccines with placebo-controlled trial evidence include hepatitis A, hepatitis B, inactivated influenza in children, typhoid, meningococcal polysaccharide and pneumococcal products in some populations; a publicly compiled database assembled by infectious-disease researchers in 2025 catalogued hundreds of placebo-controlled vaccine trials involving hundreds of thousands of participants.
• The COVID-19 vaccine is not even a long-standing 'childhood vaccine' in most schedules, and its placebo-controlled pediatric trials were methodologically ordinary rather than unique.
• This claim (in its RFK Jr. formulation, 'none of the childhood vaccines except COVID were tested against placebo') has been rated False or misleading by multiple independent fact-checking organizations and professional medical bodies, and has continued to circulate after correction.

93/100 — the lab’s own confidence in the score above, not a second reading of the claim.

New England Journal of Medicine (Vesikari et al., RotaTeq REST trial)journal · 97 · New England Journal of Medicine (Ruiz-Palacios et al., Rotarix trial)journal · 97 · U.S. Food and Drug Administrationgov · 95 · U.S. Food and Drug Administrationgov · 95 · U.S. Food and Drug Administrationgov · 93 · Wikipedia (summary of the 1954 Francis Field Trial)other · 68 · World Health Organizationgov · 92

• COVID-19 vaccines used in children were tested in placebo-controlled trials. For example, the Pfizer-BioNTech BNT162b2 trial in children 5-11 was a randomized placebo-controlled trial, and FDA labeling for Comirnaty describes placebo-controlled clinical-study data in pediatric age groups.
• There is a kernel of context: some newer or combination childhood vaccines have been evaluated against active comparators rather than inert placebo, especially when an effective vaccine already existed, so it is true that not every childhood vaccine has a modern inert-placebo prelicensure trial.

• The word “only” is false. Rotavirus vaccine is a routine childhood vaccine on the CDC schedule, and the RotaTeq Rotavirus Efficacy and Safety Trial randomized about 68,000 infants to vaccine or placebo.
• Varicella vaccine is also a routine childhood vaccine, and an efficacy trial of live attenuated varicella vaccine in healthy children was placebo-controlled.
• HPV vaccine is routinely recommended for children/adolescents, and key HPV vaccine trials were placebo-controlled, though some enrolled older adolescents and young adults rather than only younger children.
• The CDC child/adolescent immunization schedule includes multiple vaccines besides COVID-19; published placebo-controlled trials exist for several of them, so the claim as written is contradicted by the medical literature.

94/100 — the lab’s own confidence in the score above, not a second reading of the claim.

U.S. Food and Drug Administrationgov · 97 · New England Journal of Medicinejournal · 95 · Centers for Disease Control and Preventiongov · 96 · New England Journal of Medicinejournal · 95 · PubMed / National Library of Medicinejournal · 93 · New England Journal of Medicinejournal · 94

• The origin of this claim stems from a misunderstanding or deliberate misrepresentation of clinical trial ethics. It is true that many newer childhood vaccines, or updated formulations of existing vaccines (like newer pneumococcal or DTaP vaccines), are tested against 'active comparators' (the older, previously approved vaccine) rather than an inert saline placebo. Under international ethical guidelines like the Declaration of Helsinki, it is considered unethical to leave a control group of children entirely unprotected with a placebo when a safe and effective vaccine for that disease already exists. However, extrapolating this specific constraint on newer iterations to claim no childhood vaccines were ever tested against placebos is entirely false.

• Numerous childhood vaccines were subjected to massive, double-blind, placebo-controlled randomized trials prior to their approval, specifically because they were developed when no prior alternative existed.
• The 1954 Salk polio vaccine field trials—one of the largest medical experiments in history—involved over 1.8 million children. Hundreds of thousands of these children were part of a strict double-blind, placebo-controlled arm where they received an inert injection.
• In the 2000s, the rotavirus vaccines (RotaTeq and Rotarix), which are standard on the childhood immunization schedule, were evaluated in some of the largest placebo-controlled clinical trials ever conducted. The RotaTeq trials involved nearly 70,000 infants who received either the vaccine or a true placebo to rigorously monitor efficacy and check for rare adverse events like intussusception.
• The original measles and varicella (chickenpox) vaccines were also evaluated using placebo-controlled trials before they were licensed.
• The statement is a famous and repeatedly debunked piece of anti-vaccine misinformation often spread by prominent skeptics. Multiple scientific journals, government health agencies, and independent fact-checkers have thoroughly documented the extensive placebo-controlled testing history of routine childhood vaccines.

100/100 — the lab’s own confidence in the score above, not a second reading of the claim.

New England Journal of Medicinejournal · 100 · National Institutes of Healthgov · 100 · Centers for Disease Control and Preventiongov · 100

• The claim can be supported only under a narrow interpretation: many childhood vaccines were not licensed on the basis of a long-term placebo-controlled trial, and some trials used active comparators rather than an inert placebo. A congressional witness made this narrower argument, stating that vaccines on the CDC childhood schedule were not licensed based on long-term placebo-controlled trials. [https://www.congress.gov/118/meeting/house/117456/witnesses/HHRG-118-JU05-Wstate-SiriEsqA-20240626.pdf]
• The claim is also consistent with statements from HHS and Robert F. Kennedy Jr. that, except for COVID-19 vaccines, childhood-schedule vaccines were not tested against an inert placebo. However, those statements have been challenged by published trial evidence and independent reviews. [https://www.factcheck.org/2025/05/hhs-advances-kennedys-old-placebo-vaccine-safety-claims/]

• The statement is false as written because multiple childhood vaccines—not only COVID-19 vaccines—have been tested in randomized placebo-controlled trials. FactCheck.org specifically identifies rotavirus vaccines as an example. [https://www.factcheck.org/2025/05/hhs-advances-kennedys-old-placebo-vaccine-safety-claims/]
• A review reported that at least nine of the 16 vaccines routinely recommended for U.S. children had been tested against inert placebos, including vaccines for rotavirus, polio, influenza, measles-mumps-rubella, HPV, varicella, pneumococcal disease, and Haemophilus influenzae type b. [https://www.cnn.com/2025/06/05/health/vaccine-placebo-studies-kennedy]
• The 1954 Salk polio vaccine trial randomized more than 600,000 children and compared vaccination with a saltwater control, directly disproving the assertion that COVID-19 was the only childhood vaccine tested in a placebo-controlled trial. [https://www.the-independent.com/news/world/americas/rfk-jr-vaccines-fact-check-health-b2777662.html]
• A scientific review in CIDRAP describes placebo-controlled trials for mumps, varicella, rotavirus, Hib, Tdap, pneumococcal, meningococcal, HPV, influenza, and COVID-19 vaccines. [https://www.cidrap.umn.edu/childhood-vaccines/cidrap-op-ed-vaccine-myths-wont-die-and-how-counter-them-part-1]
• The existence of placebo-controlled trials does not mean every vaccine used an inert saline placebo in its pivotal licensure trial. Some studies used active controls or other comparator formulations, and ethical considerations can favor comparison with an existing vaccine. [https://www.chop.edu/vaccine-update-healthcare-professionals/newsletter/scicheck]

96/100 — the lab’s own confidence in the score above, not a second reading of the claim.

FactCheck.orgfactcheck · 95 · CNNnews · 88 · The Independentnews · 84 · Center for Infectious Disease Research and Policy, University of Minnesotaedu · 91 · Children's Hospital of Philadelphiaedu · 92 · U.S. Congressgov · 78

• Pfizer-BioNTech and Moderna COVID-19 vaccines underwent randomized, double-blind, saline-placebo-controlled trials in children before authorization, because no prior COVID vaccine existed for that age group.
• Ethical rules generally bar inert-placebo arms once an effective vaccine already exists, so many later childhood-schedule products used active comparators instead of saline.

• The 1954 Salk inactivated-polio field trial was a large randomized, placebo-controlled study in children that used saline placebo.
• RotaTeq and Rotarix rotavirus vaccines were licensed after large international placebo-controlled RCTs in infants.
• Gardasil HPV vaccine phase-3 trials (and subsequent pediatric immunogenicity trials) were placebo-controlled.
• Hepatitis A, original measles, varicella, and several other pediatric vaccines likewise included placebo-controlled trials when first developed, so COVID-19 shots are not unique.

85/100 — the lab’s own confidence in the score above, not a second reading of the claim.

New England Journal of Medicinejournal · 96 · New England Journal of Medicinejournal · 96 · New England Journal of Medicinejournal · 96